corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 20583

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Bowie C
Sales reps struggling with the new NHS environment
Pharma Times 2013 Aug 30
http://www.pharmatimes.com/Article/13-08-30/Sales_reps_struggling_with_the_new_NHS_environment.aspx


Full text:

Just 20% of representatives taking part in a recent cross-industry benchmarking competition feel very well informed about the NHS changes, according to a new Sales Insights report from PharmaTimes.

Although 60% feel reasonably informed, worryingly, 20% do not feel sufficiently well informed and, by way of example, only 50% are aware of the role of the health and wellbeing boards.

Related Links
Winners revealed in salesforce competition
Which medical reps are the most popular with doctors?
Lilly tops the poll for best sales reps
This translated into their calls with doctors. Although the majority of both primary and secondary care representatives demonstrated a very high level of understanding of their disease area, up to 12% were judged not sufficiently competent in terms of understanding other products in the therapy area, and did not demonstrate the expected level of understanding of the environment in which the doctor was working.

However, whereas some representatives were highly motivated and well equipped to deal with the latest NHS changes, others said they had lost confidence in management to provide appropriate direction through these complex marketplace changes.

Additionally, some representatives describe a company move to an account management model with a clearly ‘joined up’ strategy and implementation, while others feel their organisations have simply ‘jumped on the account management bandwagon’ without apparent strategy or adequate training, support and implementation.

The two common characteristics shared by most of the representatives, however, were enthusiasm and passion for establishing relationships with customers and the strongly held belief that their role enables them to make a real contribution to the improvement of patient care. They become frustrated when they encounter what they perceive to be sub-optimal patient care as a result of organisational change or an agenda driven too strongly by cost.

Overall, the gap between the best representatives and the rest widened this year, with the top performers doing better than top performers last year, but with the poorest performers remaining at an unacceptable level – particularly in terms of summarising the discussions and checking for doctor understanding, closing the call and asking for action and demonstrating a win:win:win for doctor, patient and company.

Around 10% of the hospital specialist representatives struggled in this area and this figure increased dramatically to nearly 40% of the primary care representatives.

Yet unless the doctor is able to assimilate the information from the call and see a benefit for the patient and for the practice, he or she is very unlikely to take any action as a result. On average the doctors expect that about 50% of calls will have a major impact on their thinking with respect to the specific product being discussed. So the perception of healthcare professionals – made in just 15 minutes – has a potentially huge impact on company performance and product uptake. Not only are the lower performers not helping, they may actually be harming the company, its reputation and its success.

These data were generated as part of the PharmaTimes Sales Awards, where sales professionals are nominated and judged by their customers. This year’s Sales Insights report benchmarks the performance of representatives from 40 companies operating in the UK. This is the largest cross company competition of its kind and the only truly external opportunity to benchmark sales performance. For more information and to register your interest in purchasing the report, which can also be personalised for your company, contact hannah@pharmatimes.com.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909